Topic: clinical trials
-
Trump Admin Canceled 383 Clinical Trials, Dropping 74,000 Patients
A major reduction in federal funding led to the abrupt termination of 383 clinical trials, directly impacting over 74,000 participants and disrupting medical research and patient welfare. The $1.8 billion cut from NIH grants, analyzed by Harvard researchers, resulted in significant inefficiency, ...
Read More » -
Cambridge Biotech STORM Therapeutics Secures $56M Funding
STORM Therapeutics secured $56 million in Series C funding to advance its RNA-modifying enzyme inhibitors, coinciding with the first patient dosed in a Phase 2 trial for its lead cancer drug, STC-15. The oral drug STC-15 inhibits the METTL3 enzyme to disrupt a corrupted RNA modification process i...
Read More » -
Anthropic's pharma deal takes aim at drug paperwork
ICON plc has entered a multi-year collaboration with Anthropic to deploy Claude across the clinical trial lifecycle, focusing on operational bottlenecks like study enrolment, which causes delays in up to 80% of trials. The partnership targets recruitment, paperwork, and scheduling through four ca...
Read More » -
Living With a Brain-Computer Interface Implant
Scott Imbrie, paralyzed since 1985, regained the ability to control a robotic arm and feel touch through a brain-computer interface (BCI) implant, a milestone achieved after joining a University of Chicago clinical trial in 2020. A small group of pioneering BCI users, organized in advocacy coalit...
Read More » -
Rivia Secures €13M to Power Clinical Trials with AI Agents
Rivia, a Zurich-based startup, has secured €13 million in funding to advance its AI-driven platform for actively managing and optimizing clinical trial operations, moving beyond passive data storage. The platform addresses data fragmentation in clinical research by integrating disparate sources a...
Read More » -
New Cancer Treatment May Also Revolutionize Autoimmune Care
Jan Janisch-Hanzlik, whose multiple sclerosis had severely deteriorated her independence, persistently contacted the University of Nebraska Medical Center until she was enrolled as the first patient in a clinical trial for CAR T cell therapy. Originally developed for cancer, CAR T therapy reprogr...
Read More » -
Cambridge startup builds chest 'foundation model' to speed drug trials
Qureight raised $20 million to build a unified chest "foundation model" that understands the entire chest, from which specialized AI tools for individual lung and heart diseases can be spun out. The Series B funding was led by Molten Ventures, and Qureight's platform aims to speed up drug develop...
Read More » -
Cancer-Detecting Brain Implants Tested in 3 People
Coherence Neuro, a startup with ties to Neuralink, has begun human testing of a brain-computer interface that detects and treats cancer by sensing electrical signals from tumors and delivering mild electrical stimulation to inhibit their growth. The coin-sized device was temporarily implanted in ...
Read More » -
DeepMind Spinoff’s AI-Designed Drugs Enter Human Trials
Isomorphic Labs, a Google DeepMind spinoff, is preparing to launch human clinical trials for drugs designed by its Nobel Prize-winning AlphaFold AI platform, marking a critical test for AI-designed medicines. The company's AlphaFold technology, which predicts protein structures and won the 2024 N...
Read More » -
Path to Long-Term HIV Remission
HIV has transitioned to a manageable chronic condition, yet a definitive cure remains elusive, necessitating lifelong antiretroviral therapy for viral control. Recent clinical trials in 2025 demonstrated that antibody infusions enabled some participants to achieve long-term viral suppression with...
Read More » -
Aloe Blacc's Biotech Role Values Expertise Over Fame
Aloe Blacc is personally developing a cancer drug platform for pancreatic cancer after his experience with COVID-19 revealed the complexities of biotech innovation, which requires more than just funding. He is intentionally bootstrapping early research to generate peer-reviewed data, believing ex...
Read More » -
Neuralink's Brain Implant Challenges
Neuralink's initial vision for human enhancement through motor-based brain-computer interfaces (BCIs) has faced significant scientific and practical hurdles, leading to a strategic pivot toward speech restoration technology. The BCI field has seen rapid progress in speech decoding, achieving high...
Read More » -
Groundbreaking Cancer Therapy: A New Hope for MS?
Grace Miller, a 46-year-old with multiple sclerosis (MS), joined an early clinical trial exploring CAR-T therapy, a cancer treatment, for its potential to halt MS progression by targeting rogue B cells that attack nerve fibers. CAR-T therapy involves genetically engineering a patient's own immune c...
Read More » -
Unconventional Lab Pioneers New Drug Discovery
Professor Kelly Chibale founded the H3D Centre at the University of Cape Town to establish a world-class, Africa-based drug discovery pipeline, shifting research agendas to address diseases like malaria and tuberculosis that disproportionately affect the continent. The center's integrated researc...
Read More » -
French Startup Builds AI-Powered Radiology Viewer Used by Moffitt Cancer Center
Raidium, a French-American startup, has launched its AI-native imaging platform, Raidium Read, at Moffitt Cancer Center, replacing older radiomics applications for clinical trials and research, with FDA 510(k) clearance expected by year-end. The platform uses deep learning to analyze medical imag...
Read More » -
Trump Mystery Patient in 79-Year-Old’s Experimental Obesity Drug Case
The FDA granted a single 79-year-old patient early access to Eli Lilly's experimental obesity drug retatrutide through its compassionate use program, sparking speculation that the recipient could be President Donald Trump, who turned 80 in June. Retatrutide is a next-generation obesity treatment ...
Read More » -
The Real Challenges of Commercializing Brain Technology
The development of brain-computer interfaces (BCIs) from lab concept to market faces significant scientific, technical, and market challenges, requiring extensive research and collaboration. Key hurdles include identifying viable applications that meet real human needs and ensuring reliable perfo...
Read More » -
Novo Nordisk breach exposes clinical trial data
Novo Nordisk confirmed a data breach where attackers accessed pseudonymized patient data from clinical trials, including IDs, health information, and lifestyle factors, but stated the data cannot directly identify patients by name. The breach also exposed personal details of healthcare profession...
Read More » -
Science Corp Secures $230M for Brain Implant Market Push
Science Corporation, a brain-computer interface startup, has raised $230 million in Series C funding, valuing the company at $1.5 billion to commercialize its first product. Its initial product, the PRIMA sub-retinal implant, has shown in clinical trials to restore reading ability for 80% of pati...
Read More » -
China's Brain-Computer Interface Industry Surges Ahead
China's brain-computer interface (BCI) sector is rapidly commercializing, driven by strong policy support, extensive clinical resources, and significant capital investment, with several provinces already establishing medical pricing for procedures. The technology is evolving from medical applicat...
Read More »